Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

2025-524043-12-00
Recruiting
A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in healthy adults
Phase 1 · Germany · 1 site
Registry update: 1 Oct 2026
NCT07764133
Recruiting
Whole Body Metabolic Activity as a Reflection of Tumor Metabolic Dysregulation and a Predictor of Treatment Response in Ovarian Cancer
Not applicable · United States · 1 site
Registry update: 17 Aug 2026
NCT07454798
Recruiting
A Feasibility Trial of Virtual Reality Neurofeedback for Adolescents With Migraine
Not applicable · United States · 1 site
Registry update: 3 Jun 2026
NCT07594275
Recruiting
Interoception and Illness Perception Before and After Bariatric Surgery: Impact on Disordered Eating (Interoceptiv-BAR)
Not applicable · Italy · 1 site
Registry update: 3 Sept 2026
NCT07366684
Recruiting
Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome
Not applicable · Serbia · 1 site
Registry update: 15 May 2026
NCT06882486
Recruiting
Post-immunotherapy Nephrectomy for Metastatic Kidney Cancer After Complete or Major Response to Systemic Therapy
Not applicable · France · 1 site
Registry update: 14 Oct 2026
NCT07574619
Recruiting
Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based Approach
Not applicable · Uganda · 1 site
Registry update: 18 May 2026
NCT07202754
Recruiting
Procedural Complications and Long-Term Mortality in Complex Coronary Interventions
Not applicable · 1 site
Registry update: 9 Jul 2026
NCT06930755
Recruiting
Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer
Phase 1 · United States · 5 sites
Registry update: 28 May 2026
NCT07838714
Recruiting
Dual-Targeted Umbilical Cord Blood CAR-T Cells Against CD19 and CD22 for the Treatment of Relapsed or Refractory Acute B-Cell Lymphoblastic Leukemia
Phase 1 · China · 1 site
Registry update: 25 Sept 2026
NCT07133997
Recruiting
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
Phase 1 · United States · 1 site
Registry update: 16 Oct 2026
NCT07596121
Recruiting
Serplulimab Monotherapy in Elderly Patients With NSCLC and PD-L1 TPS ≥ 50%
Phase 2 · China · 1 site
Registry update: 19 May 2026
NCT07497607
Recruiting
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 18 May 2026
NCT07816692
Recruiting
iDose TR Administration in an Office-Based Surgery Setting
Not applicable · United States · 1 site
Registry update: 30 Sept 2026
NCT06641310
Recruiting
Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)
Not applicable · United States · 2 sites
Registry update: 19 May 2026
NCT07589244
Recruiting
A Study of VRT106, Combined With Camrelizumab, and Apatinib for Advanced HCC
Phase 2/3 · China · 1 site
Registry update: 30 Oct 2026
NCT07708714
Recruiting
Optimizing Hydroxyurea Therapy in Children With Sickle Cell Anemia In Malaria Endemic Areas: The NOHARM Maximum Tolerated Dose (MTD) Study
Phase 1/2 · Uganda · 1 site
Registry update: 16 Jul 2026
NCT07640555
Recruiting
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
Early phase 1 · United States · 1 site
Registry update: 10 Jun 2026
NCT07483658
Recruiting
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
Not applicable · Canada · 4 sites
Registry update: 1 Jul 2026
NCT06465199
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Phase 1/2 · United States · 14 sites
Registry update: 3 Sept 2026

Ordered by registry start date. Freshness and sponsorship never change the order.